JAK and PI3K Signaling Pathway Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: JB809F9C2782EN
Market Monitor Global

Abstracts

Therapies related to the JAK and PI3K signaling pathways have the potential to target diseases such as cancer and inflammatory diseases, and no suitable drugs are currently available. Current therapies can reduce the burden of disease, but they cannot be cured.

This report contains market size and forecasts of JAK and PI3K Signaling Pathway in Global, including the following market information:

Global JAK and PI3K Signaling Pathway Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global JAK and PI3K Signaling Pathway market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PI3K Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of JAK and PI3K Signaling Pathway include Bayer HealthCare Pharmaceuticals, AbbVie, AstraZeneca, Curis, Daiichi Sankyo, Exelixis, Genentech, Infinity Pharmaceuticals and Merck & Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the JAK and PI3K Signaling Pathway companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global JAK and PI3K Signaling Pathway Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global JAK and PI3K Signaling Pathway Market Segment Percentages, by Type, 2021 (%)

• PI3K
• Janus Kinase Therapies (Inhibitors)
• PI3K Therapies (Inhibitors)
• Signal Transduction Biomarkers for JAK and PI3K

Global JAK and PI3K Signaling Pathway Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global JAK and PI3K Signaling Pathway Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Inflammatory Diseases
• Cardiac Ailments
• Others

Global JAK and PI3K Signaling Pathway Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global JAK and PI3K Signaling Pathway Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies JAK and PI3K Signaling Pathway revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies JAK and PI3K Signaling Pathway revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer HealthCare Pharmaceuticals
• AbbVie
• AstraZeneca
• Curis
• Daiichi Sankyo
• Exelixis
• Genentech
• Infinity Pharmaceuticals
• Merck & Co.
• Rigel Pharmaceuticals
• TG Therapeutics
• Sanofi Oncology
• Vertex Pharmaceuticals
• WILEX AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 JAK and PI3K Signaling Pathway Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global JAK and PI3K Signaling Pathway Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL JAK AND PI3K SIGNALING PATHWAY OVERALL MARKET SIZE

2.1 Global JAK and PI3K Signaling Pathway Market Size: 2021 VS 2028
2.2 Global JAK and PI3K Signaling Pathway Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top JAK and PI3K Signaling Pathway Players in Global Market
3.2 Top Global JAK and PI3K Signaling Pathway Companies Ranked by Revenue
3.3 Global JAK and PI3K Signaling Pathway Revenue by Companies
3.4 Top 3 and Top 5 JAK and PI3K Signaling Pathway Companies in Global Market, by Revenue in 2021
3.5 Global Companies JAK and PI3K Signaling Pathway Product Type
3.6 Tier 1, Tier 2 and Tier 3 JAK and PI3K Signaling Pathway Players in Global Market
  3.6.1 List of Global Tier 1 JAK and PI3K Signaling Pathway Companies
  3.6.2 List of Global Tier 2 and Tier 3 JAK and PI3K Signaling Pathway Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global JAK and PI3K Signaling Pathway Market Size Markets, 2021 & 2028
  4.1.2 PI3K
  4.1.3 Janus Kinase Therapies (Inhibitors)
  4.1.4 PI3K Therapies (Inhibitors)
  4.1.5 Signal Transduction Biomarkers for JAK and PI3K
4.2 By Type - Global JAK and PI3K Signaling Pathway Revenue & Forecasts
  4.2.1 By Type - Global JAK and PI3K Signaling Pathway Revenue, 2017-2022
  4.2.2 By Type - Global JAK and PI3K Signaling Pathway Revenue, 2023-2028
  4.2.3 By Type - Global JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global JAK and PI3K Signaling Pathway Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Inflammatory Diseases
  5.1.4 Cardiac Ailments
  5.1.5 Others
5.2 By Application - Global JAK and PI3K Signaling Pathway Revenue & Forecasts
  5.2.1 By Application - Global JAK and PI3K Signaling Pathway Revenue, 2017-2022
  5.2.2 By Application - Global JAK and PI3K Signaling Pathway Revenue, 2023-2028
  5.2.3 By Application - Global JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global JAK and PI3K Signaling Pathway Market Size, 2021 & 2028
6.2 By Region - Global JAK and PI3K Signaling Pathway Revenue & Forecasts
  6.2.1 By Region - Global JAK and PI3K Signaling Pathway Revenue, 2017-2022
  6.2.2 By Region - Global JAK and PI3K Signaling Pathway Revenue, 2023-2028
  6.2.3 By Region - Global JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America JAK and PI3K Signaling Pathway Revenue, 2017-2028
  6.3.2 US JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.3.3 Canada JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.3.4 Mexico JAK and PI3K Signaling Pathway Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe JAK and PI3K Signaling Pathway Revenue, 2017-2028
  6.4.2 Germany JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.4.3 France JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.4.4 U.K. JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.4.5 Italy JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.4.6 Russia JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.4.7 Nordic Countries JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.4.8 Benelux JAK and PI3K Signaling Pathway Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia JAK and PI3K Signaling Pathway Revenue, 2017-2028
  6.5.2 China JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.5.3 Japan JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.5.4 South Korea JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.5.5 Southeast Asia JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.5.6 India JAK and PI3K Signaling Pathway Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America JAK and PI3K Signaling Pathway Revenue, 2017-2028
  6.6.2 Brazil JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.6.3 Argentina JAK and PI3K Signaling Pathway Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa JAK and PI3K Signaling Pathway Revenue, 2017-2028
  6.7.2 Turkey JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.7.3 Israel JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.7.4 Saudi Arabia JAK and PI3K Signaling Pathway Market Size, 2017-2028
  6.7.5 UAE JAK and PI3K Signaling Pathway Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer HealthCare Pharmaceuticals
  7.1.1 Bayer HealthCare Pharmaceuticals Corporate Summary
  7.1.2 Bayer HealthCare Pharmaceuticals Business Overview
  7.1.3 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Major Product Offerings
  7.1.4 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.1.5 Bayer HealthCare Pharmaceuticals Key News
7.2 AbbVie
  7.2.1 AbbVie Corporate Summary
  7.2.2 AbbVie Business Overview
  7.2.3 AbbVie JAK and PI3K Signaling Pathway Major Product Offerings
  7.2.4 AbbVie JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.2.5 AbbVie Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca JAK and PI3K Signaling Pathway Major Product Offerings
  7.3.4 AstraZeneca JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Curis
  7.4.1 Curis Corporate Summary
  7.4.2 Curis Business Overview
  7.4.3 Curis JAK and PI3K Signaling Pathway Major Product Offerings
  7.4.4 Curis JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.4.5 Curis Key News
7.5 Daiichi Sankyo
  7.5.1 Daiichi Sankyo Corporate Summary
  7.5.2 Daiichi Sankyo Business Overview
  7.5.3 Daiichi Sankyo JAK and PI3K Signaling Pathway Major Product Offerings
  7.5.4 Daiichi Sankyo JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.5.5 Daiichi Sankyo Key News
7.6 Exelixis
  7.6.1 Exelixis Corporate Summary
  7.6.2 Exelixis Business Overview
  7.6.3 Exelixis JAK and PI3K Signaling Pathway Major Product Offerings
  7.6.4 Exelixis JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.6.5 Exelixis Key News
7.7 Genentech
  7.7.1 Genentech Corporate Summary
  7.7.2 Genentech Business Overview
  7.7.3 Genentech JAK and PI3K Signaling Pathway Major Product Offerings
  7.7.4 Genentech JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.7.5 Genentech Key News
7.8 Infinity Pharmaceuticals
  7.8.1 Infinity Pharmaceuticals Corporate Summary
  7.8.2 Infinity Pharmaceuticals Business Overview
  7.8.3 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Major Product Offerings
  7.8.4 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.8.5 Infinity Pharmaceuticals Key News
7.9 Merck & Co.
  7.9.1 Merck & Co. Corporate Summary
  7.9.2 Merck & Co. Business Overview
  7.9.3 Merck & Co. JAK and PI3K Signaling Pathway Major Product Offerings
  7.9.4 Merck & Co. JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.9.5 Merck & Co. Key News
7.10 Rigel Pharmaceuticals
  7.10.1 Rigel Pharmaceuticals Corporate Summary
  7.10.2 Rigel Pharmaceuticals Business Overview
  7.10.3 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Major Product Offerings
  7.10.4 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.10.5 Rigel Pharmaceuticals Key News
7.11 TG Therapeutics
  7.11.1 TG Therapeutics Corporate Summary
  7.11.2 TG Therapeutics Business Overview
  7.11.3 TG Therapeutics JAK and PI3K Signaling Pathway Major Product Offerings
  7.11.4 TG Therapeutics JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.11.5 TG Therapeutics Key News
7.12 Sanofi Oncology
  7.12.1 Sanofi Oncology Corporate Summary
  7.12.2 Sanofi Oncology Business Overview
  7.12.3 Sanofi Oncology JAK and PI3K Signaling Pathway Major Product Offerings
  7.12.4 Sanofi Oncology JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.12.5 Sanofi Oncology Key News
7.13 Vertex Pharmaceuticals
  7.13.1 Vertex Pharmaceuticals Corporate Summary
  7.13.2 Vertex Pharmaceuticals Business Overview
  7.13.3 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Major Product Offerings
  7.13.4 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.13.5 Vertex Pharmaceuticals Key News
7.14 WILEX AG
  7.14.1 WILEX AG Corporate Summary
  7.14.2 WILEX AG Business Overview
  7.14.3 WILEX AG JAK and PI3K Signaling Pathway Major Product Offerings
  7.14.4 WILEX AG JAK and PI3K Signaling Pathway Revenue in Global Market (2017-2022)
  7.14.5 WILEX AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. JAK and PI3K Signaling Pathway Market Opportunities & Trends in Global Market
Table 2. JAK and PI3K Signaling Pathway Market Drivers in Global Market
Table 3. JAK and PI3K Signaling Pathway Market Restraints in Global Market
Table 4. Key Players of JAK and PI3K Signaling Pathway in Global Market
Table 5. Top JAK and PI3K Signaling Pathway Players in Global Market, Ranking by Revenue (2021)
Table 6. Global JAK and PI3K Signaling Pathway Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global JAK and PI3K Signaling Pathway Revenue Share by Companies, 2017-2022
Table 8. Global Companies JAK and PI3K Signaling Pathway Product Type
Table 9. List of Global Tier 1 JAK and PI3K Signaling Pathway Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 JAK and PI3K Signaling Pathway Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - JAK and PI3K Signaling Pathway Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - JAK and PI3K Signaling Pathway Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - JAK and PI3K Signaling Pathway Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - JAK and PI3K Signaling Pathway Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global JAK and PI3K Signaling Pathway Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global JAK and PI3K Signaling Pathway Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2023-2028
Table 30. Bayer HealthCare Pharmaceuticals Corporate Summary
Table 31. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Product Offerings
Table 32. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie JAK and PI3K Signaling Pathway Product Offerings
Table 35. AbbVie JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca JAK and PI3K Signaling Pathway Product Offerings
Table 38. AstraZeneca JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 39. Curis Corporate Summary
Table 40. Curis JAK and PI3K Signaling Pathway Product Offerings
Table 41. Curis JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 42. Daiichi Sankyo Corporate Summary
Table 43. Daiichi Sankyo JAK and PI3K Signaling Pathway Product Offerings
Table 44. Daiichi Sankyo JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 45. Exelixis Corporate Summary
Table 46. Exelixis JAK and PI3K Signaling Pathway Product Offerings
Table 47. Exelixis JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 48. Genentech Corporate Summary
Table 49. Genentech JAK and PI3K Signaling Pathway Product Offerings
Table 50. Genentech JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 51. Infinity Pharmaceuticals Corporate Summary
Table 52. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Product Offerings
Table 53. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 54. Merck & Co. Corporate Summary
Table 55. Merck & Co. JAK and PI3K Signaling Pathway Product Offerings
Table 56. Merck & Co. JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 57. Rigel Pharmaceuticals Corporate Summary
Table 58. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Product Offerings
Table 59. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 60. TG Therapeutics Corporate Summary
Table 61. TG Therapeutics JAK and PI3K Signaling Pathway Product Offerings
Table 62. TG Therapeutics JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 63. Sanofi Oncology Corporate Summary
Table 64. Sanofi Oncology JAK and PI3K Signaling Pathway Product Offerings
Table 65. Sanofi Oncology JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 66. Vertex Pharmaceuticals Corporate Summary
Table 67. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Product Offerings
Table 68. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)
Table 69. WILEX AG Corporate Summary
Table 70. WILEX AG JAK and PI3K Signaling Pathway Product Offerings
Table 71. WILEX AG JAK and PI3K Signaling Pathway Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. JAK and PI3K Signaling Pathway Segment by Type in 2021
Figure 2. JAK and PI3K Signaling Pathway Segment by Application in 2021
Figure 3. Global JAK and PI3K Signaling Pathway Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global JAK and PI3K Signaling Pathway Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global JAK and PI3K Signaling Pathway Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by JAK and PI3K Signaling Pathway Revenue in 2021
Figure 8. By Type - Global JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 9. By Application - Global JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 10. By Region - Global JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 11. By Country - North America JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 12. US JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 13. Canada JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 16. Germany JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 17. France JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 19. Italy JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 20. Russia JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 24. China JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 25. Japan JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 28. India JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 30. Brazil JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa JAK and PI3K Signaling Pathway Revenue Market Share, 2017-2028
Figure 33. Turkey JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 34. Israel JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 36. UAE JAK and PI3K Signaling Pathway Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbbVie JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Curis JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Daiichi Sankyo JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Exelixis JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genentech JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck & Co. JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. TG Therapeutics JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sanofi Oncology JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. WILEX AG JAK and PI3K Signaling Pathway Revenue Year Over Year Growth (US$, Mn) & (2017-2022)